Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H17ClN2O |
| Molecular Weight | 288.772 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CCCCC3
InChI
InChIKey=IQWYAQCHYZHJOS-UHFFFAOYSA-N
InChI=1S/C16H17ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h5,7-9H,2-4,6,10H2,1H3
| Molecular Formula | C16H17ClN2O |
| Molecular Weight | 288.772 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. | 2010-12 |
|
| Analysis of six benzodiazepines in vitreous humor by high-performance liquid chromatography-photodiode-array detection. | 2010-11 |
|
| [Multimodal treatment of chronic unspecific low back pain]. | 2010-09-14 |
|
| Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. | 2010-08-16 |
|
| Development and validation of an EI-GC-MS method for the determination of benzodiazepine drugs and their metabolites in blood: applications in clinical and forensic toxicology. | 2010-08-01 |
|
| Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator. | 2010-07 |
|
| The impact of perfectionism and anxiety traits on action monitoring in major depressive disorder. | 2010-07 |
|
| Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. | 2010-06 |
|
| Occupational allergic contact dermatitis from tetrazepam in nurses. | 2010-05 |
|
| Experimental design for optimization of microwave-assisted extraction of benzodiazepines in human plasma. | 2010-05 |
|
| Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines. | 2010-03-15 |
|
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | 2009-10-02 |
|
| Occupational airborne contact allergy to tetrazepam in a geriatric nurse. | 2009-10 |
|
| No cross-reactions between tetrazepam and other benzodiazepines: a possible chemical explanation. | 2009-07 |
|
| Lumbar spondylosis: clinical presentation and treatment approaches. | 2009-06 |
|
| Metabolic studies of tetrazepam based on electrochemical simulation in comparison to in vivo and in vitro methods. | 2009-04-10 |
|
| Unraveling the metabolic transformation of tetrazepam to diazepam with mass spectrometric methods. | 2008-12 |
|
| [Current differential diagnosis of hypereosinophilic syndrome]. | 2008-08-01 |
|
| Probable drug rash with eosinophilia and systemic symptoms syndrome related to tetrazepam. | 2008-07 |
|
| Patch testing in non-immediate drug eruptions. | 2008-06-15 |
|
| Systemic dermatitis due to tetrazepam. | 2008 |
|
| Acute generalized exanthematous pustulosis due to tetrazepam. | 2008 |
|
| Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan and Valium. | 2007-08 |
|
| [Comparative study on Chinese medicine and western medicine for treatment of prolapse of lumbar intervertebral disc]. | 2007-05 |
|
| Medicolegal aspects of tetrazepam metabolism. | 2007-05 |
|
| Development of in situ ion selective sensors for dissolution. | 2007-01-02 |
|
| Erythema multiforme to tetrazepam. | 2007 |
|
| Toxic epidermal necrolysis caused by tetrazepam. | 2006-10 |
|
| Toxic epidermal necrolysis caused by tetrazepam. | 2006-04 |
|
| Determination of ibuprofen and tetrazepam in human urine by micellar electrokinetic capillary chromatography. | 2006-01 |
|
| Screening method for benzodiazepines and hypnotics in hair at pg/mg level by liquid chromatography-mass spectrometry/mass spectrometry. | 2005-10-15 |
|
| Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes. | 2005-10 |
|
| Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS. | 2005-06-10 |
|
| Medicinal and injection therapies for mechanical neck disorders. | 2005-04-18 |
|
| Occupational airborne contact dermatitis from sporadic exposure to tetrazepam during machine maintenance. | 2005-03 |
|
| [Drug Safety. Preventing medication errors]. | 2004-09-17 |
|
| Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. | 2004-08 |
|
| Sex-dependent modulation of treatment response. | 2004-03 |
|
| Possible mechanism(s) for relaxant effect of aqueous and macerated extracts from Nigella sativa on tracheal chains of guinea pig. | 2004-02-25 |
|
| Occupational airborne contact allergy to tetrazepam. | 2003-11 |
|
| Major bleeding during combined treatment with indomethacin and low doses of acenocoumarol in a homozygous patient for 2C9*3 variant of cytochrome p-450 CYP2C9. | 2003-07 |
|
| [Medical treatment of spasticity]. | 2003-05 |
|
| [Determination of benzodiazepine derivatives mixture by high performance liquid chromatography]. | 2003 |
|
| Direct injection micellar liquid chromatographic determination of benzodiazepines in serum. | 2002-11-25 |
|
| Formulating and stability of benzodiazepines in a new lipid emulsion formulation. | 2002-11 |
|
| Tetrazepam drug sensitivity -- usefulness of the patch test. | 2002-09 |
|
| [Analysis of benzodiazepine derivative mixture by gas-liquid chromatography]. | 2002 |
|
| Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. | 2001-12 |
|
| Development of a novel parenteral formulation for tetrazepam using a lipid emulsion. | 2001-11 |
|
| Adverse reaction to tetrazepam. | 2001 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2883980
Tetrazepam was given orally as a single dose of 50 mg and repeated administration for 5 consecutive days of 50 mg at 12-h intervals, in tablet form
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:19 GMT 2025
by
admin
on
Mon Mar 31 17:58:19 GMT 2025
|
| Record UNII |
FO92091VP8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QM03BX07
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
WHO-ATC |
M03BX07
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
DEA NO. |
2886
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2182
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
100000082738
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
2614
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105527
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
m10661
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
FO92091VP8
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
25215
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
DB13324
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
TETRAZEPAM
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
SUB10946MIG
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
10379-14-3
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
C74282
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
DTXSID00146058
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
233-837-7
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
37985
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
C005245
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |